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Estrogens have multiple actions in the brain including modulating synaptic plasticity, con-
nectivity, and cognitive behaviors. While the classical view of estrogens are as endocrine
signals, whose effectsmanifest via the regulation of gene transcription, mounting evidence
has been presented demonstrating that estrogens have rapid effects within speciﬁc areas
of the brain. The emergence that 17 β-estradiol can be produced locally in the brain which
can elicit rapid (within minutes) cellular responses has led to its classiﬁcation as a neu-
rosteroid. Moreover, recent studies have also begun to detail the molecular and cellular
underpinnings of how 17 β-estradiol can rapidlymodulate spiny synapses (dendritic spines).
Remodeling of dendritic spines is a key step in the rewiring of neuronal circuitry thought
to underlie the processing and storage of information in the forebrain. Conversely, abnor-
mal remodeling of dendritic spines is thought to contribute to a number of psychiatric and
neurodevelopmental disorders. Here we review recent molecular and cellular work that
offers a potential mechanism of how 17 β-estradiol may modulate synapse structure and
function of cortical neurons.This mechanism allows cortical neurons to respond to activity-
dependent stimuli with greater efﬁcacy. In turn this form of plasticity may provide an insight
into how 17 β-estradiol can modulate the rewiring of neuronal circuits, underlying its ability
to inﬂuencing cortically based behaviors. We will then go on to discuss the potential role
of 17 β-estradiol modulation of neural circuits and its potential relevance for the treatment
of psychiatric and neurodevelopmental disorders.
Keywords: cortex, 17 β-estradiol, small GTPases, signal transduction, rapid, schizophrenia, depression,Alzheimer’s
disease
INTRODUCTION
Neuronal connections in the adult brain are plastic and change in
response to a number of environmental and extracellular stimuli,
ranging from activity-dependent stimuli to neuromodulator and
neurosteroids (Alvarez and Sabatini, 2007; Bhatt et al., 2009; Brin-
ton, 2009; Holtmaat and Svoboda, 2009). This structural plasticity
is essential for normal cognitive function (Chklovskii et al., 2004;
DeBello, 2008; Bhatt et al., 2009; Holtmaat and Svoboda, 2009)
and may ameliorate progression of psychiatric and neurodegener-
ative disorders such as schizophrenia, depression, and Alzheimer’s
disease (Penzes et al., 2011a,b). However, excessive or aberrant
reorganization of neural circuits has been proposed to contribute
to psychiatric and neurodegenerative disorders, by providing a
pathological cellular mechanism by which cognitive deﬁcits seen
in such disorders may emerge (van Spronsen and Hoogenraad,
2010; Penzes et al., 2011a). Therefore, harnessing structural plas-
ticity for active therapeutic intervention requires anunderstanding
of the cellular mechanisms that underpin cortical plasticity.
It is well established that estrogens have a wide range of effects
on physiological functions ranging from reproduction, develop-
ment, and cardiovascular function. Estrogens refer to a class of
steroid compounds, of which 17 β-estradiol (herein referred to as
estradiol) is considered to be the most biologically active form.
Over recent years there has been a growing appreciation of the
complex actions of estrogens within the brain. In addition to their
actions in the hypothalamus (Kelly et al., 2005), it has become
clear that estradiol can exert effects in multiple regions of the
brains including the cerebral cortex and hippocampus (McEwen
and Alves, 1999; Brinton, 2009). The emergence of estradiol’s
actions within these areas has also been accompanied by clinical
and basic studies implicating estrogens in regulating cognitive and
memory processing in both animal models and humans (Luine,
2008; Brinton, 2009; Henderson, 2009). The effects of estrogens
on cognitive function is of signiﬁcant interest due to the grow-
ing evidence that estrogens may delay the onset or ameliorate the
severity of a number of psychiatric and neurodegenerative disor-
ders, such as schizophrenia, anxiety, depression, and Alzheimer’s
disease (Hughes et al., 2009). Therefore, elucidating the molecu-
lar and cellular mechanisms that underlie estradiol’s effects within
the brain, and how they may be relevant for neuropathologies is
essential for understanding the potential role of estrogens in these
disorders.
Despite the fact that rapid estrogenic effects within the brain
were ﬁrst reported over 40 years ago (Bueno and Pfaff, 1976),
the majority of studies to date have focused on the long-term
actions of estrogens as a circulating hormone. This classical mode
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of action for estrogens, also referred to as genomic actions, occurs
via the regulation of gene transcription, whose actions take hours
to days to manifest. However, recent studies have demonstrated
that estradiol can modulate cognitive function within minutes
to hours (Balthazart and Ball, 2006; Sinopoli et al., 2006; Phan
et al., 2011). This is paralleled with ﬁndings that estradiol can
increase synaptic plasticity in several areas of the brain, including
the hippocampus, cortex, and prefrontal cortex (PFC), also within
minutes to hours (Woolley, 2007; Srivastava et al., 2008). However,
the precise molecular mechanisms that are required for estradiol’s
ability to rapidly inﬂuence synaptic plasticity, and thus lead to
long-term changes in the cellular responses to subsequent stim-
uli, are only just becoming evident. Here we will focus on recent
insights into the actions of estradiol in the cortex. Speciﬁcally,
we will ﬁrst consider the evidence that estradiol is a neurosteroid
and may even function as a neuromodulator before going on to
examine the cellular and molecular mechanisms underlying rapid
estrogenic-dependent remodeling of cortical circuits. Finally we
will discuss how this mechanism in part, may underlie estradiol’s
ability to inﬂuence cognitive function, and its potential relevance
for psychiatric and neurodegenerative disorders.
ESTRADIOL AS A NEUROMODULATOR
The classic mode of action for estradiol in the brain is as an
endocrine signal, which travels over long distances before enter-
ing the target tissue where it exerts its effects via gene regulation
(McEwen and Alves, 1999). However, there is increasing evidence
that signiﬁcant concentrations of estradiol are produced locally
in discrete regions of the brain which can rapidly induce electro-
physiological, cellular, molecular, and behavioral effects (Woolley,
2007; Srivastava et al., 2008, 2010; Saldanha et al., 2011). Brain-
synthesized estradiol has been identiﬁed in several brain regions
of a number of avian and mammalian species (Yague et al., 2006;
Boon et al., 2010; Saldanha et al., 2011). Moreover, this de novo
production of estradiol demonstrates that it is a neurosteroid and
has led to suggestions that it may be considered a neuromodu-
lator (Balthazart and Ball, 2006; Saldanha et al., 2011). In order
for estradiol to be considered as a neuromodulator, a number of
criteria must be met.
(1) Rapid biosynthesis and breakdownof estradiol within discrete
regions of the brain.
(2) Production of estradiol must be spatially and temporally
restricted, and regulated by electrochemical events, to allow
for speciﬁc actions of the neurosteroid.
(3) Speciﬁc receptors for estradiolmust be ideally located to allow
for the coupling of estrogenic signal to elicit physiological and
cellular effects within seconds tominutes via ion channels and
second messenger pathways.
Indeed, numerous studies have demonstrated that estradiol meets
these criteria.
DE NOVO SYNTHESIS OF ESTRADIOL
Studies where the sex organs of rodents have been removed or
direct measurements of estradiol production in the zebra ﬁnch
song birds have shown that estradiol is produced rapidly within
the brain (Remage-Healey et al., 2008; Konkle and McCarthy,
2011). Furthermore, the presence of aromatase, the major enzyme
required for the synthesis of estradiol from androgen has been
identiﬁed in a number of brain regions including the hypothal-
amus, hippocampus, visual cortex, and temporal cortex in avian,
mammalian, and human brains (Rune and Frotscher, 2005; Yague
et al., 2006; Boon et al., 2010; Saldanha et al., 2011). Based on
experimental studies in the avian and mammalian brains, brain-
aromatase activity has been shown to be required for the rapid
synthesis of estradiol (Garcia-Segura, 2008; Yague et al., 2008;
Saldanha et al., 2011). The enzymes StAR (steroidogenic acute reg-
ulatory protein) 3β-HSD (3β-hydroxysteroid dehydrogenase) and
SCC (side-chain-cleavage enzyme), enzymes required for the con-
versation of cholesterol into estrogenic precursors, have also been
reported to be expressed in neurons (Wehrenberg et al., 2001).
The presence of these enzymes in neurons provides a potential
direct pathway for the biosynthesis of estrogens from cholesterol.
On the other hand, enzymes including 2- and 4-hydroxylase, and
catechol-O-methyltransferase, which are involved in the metab-
olism of estrogens into inactive (or less active) water-soluble
metabolites, have also been detected within the brain (Zhu and
Conney, 1998). Together these studies demonstrate that speciﬁc
mechanisms required for the rapid de novo synthesis and metabo-
lism of estrogens in the brain exist, supporting the hypothesis that
estradiol is a neurosteroid.
PRE-SYNAPTIC LOCALIZATION AND SYNTHESIS OF AROMATASE
A number of studies have also localized aromatase within pre-
synaptic terminals. In the hypothalamus EM studies have demon-
strated a synaptic localization for aromatase in avian,mammalian,
and human tissue (Naftolin et al., 1996). Furthermore, biochem-
ical studies have detected high levels of aromatase activity in
isolated pre-synaptic tissue preparations (Mak et al., 1985). Using
mature cultured cortical neurons derived from embryonic rats,
we ﬁnd that aromatase is present at synapses (Srivastava et al.,
2010).Aromatase co-localizeswith the post-synapticmarker,PDS-
95 (post-synaptic density protein 95), and the pre-synapticmarker
bassoon in cortical neurons (Srivastava et al., 2010). In addition,
aromatase was detected in tau5-positive axonal processes, indicat-
ing that a portion of aromatase is present at pre-synaptic terminals
(Srivastava et al., 2010). More recently, evidence has been pre-
sented that acute ﬂuctuations in brain-synthesized estradiol levels
mediated by aromatase activity in the cortex of zebra ﬁnch, is
controlled by speciﬁc depolarization-sensitive calcium-dependent
events (Remage-Healey et al., 2011). This study presents strong
evidence that locally produced estradiol within the brain is regu-
lated by electrochemical signals, strongly supporting a hypothesis
that estradiol may be considered a neuromodulator. Collectively,
the presence and regulation of aromatase at pre-synaptic termi-
nals places the machinery required for the de novo production
of estradiol at an ideal location for this neurosteroid to act on
post-synaptic structures.
LOCALIZATION OF ESTROGEN RECEPTORS IN THE BRAIN
The presence of receptors speciﬁc for estrogens in the brain has
been well documented (Brinton, 2009; Hughes et al., 2009). Estro-
gen receptor (ER) α, ERβ, and the GPCR, GPR30 (also known as
Frontiers in Endocrinology | Neuroendocrine Science November 2011 | Volume 2 | Article 77 | 2
Srivastava and Penzes Estradiol modulation of neuronal circuits
G protein-coupled ER,GPER) have been shown to be expressed in
several regions of the brain. ERα is highly expressed in the hypo-
thalamus and in themammalian forebrain,whereas ERβ has lower
expression in the hypothalamus, but is thought to be expressed
highly in the cortex and hippocampus (Milner et al., 2001, 2005;
Kritzer, 2002; Mitra et al., 2003). Furthermore, recent studies have
identiﬁed both ERα and β to reside in both pre- and post-synaptic
compartments (McEwen et al., 2001; Milner et al., 2001, 2005).
Some controversy surrounds whether estrogens are the true ligand
for GPR30 (Langer et al., 2010), nevertheless there are numerous
reports that have indicated that this receptor is highly responsive
to acute estradiol treatment (Prossnitz andMaggiolini, 2009;Mag-
giolini and Picard, 2010; Nadal et al., 2011). Investigations into the
localization of this receptor within the brain have shown expres-
sion in several areas including the cortex, hippocampus as well as
the hypothalamus (Brailoiu et al., 2007; Hazell et al., 2009). All
three receptors have been shown to be able to rapidly initiate sec-
ond messenger pathways in response to acute estradiol treatment
within neurons (Brinton, 2009). This provides a mechanism to
allow the coupling of rapid estrogenic signaling with intracellular
signaling cascades, resulting in acute cellular effects. Collectively,
these data suggest that brain-synthesized estradiol does fulﬁll the
criteria required for the consideration of estradiol as a neuro-
modulator as outlined above. Moreover, these studies support
a hypothesis that brain-synthesized estradiol can initiate rapid
cellular effects, altering post-synaptic structures, and may be a
mechanism whereby cognition and behavior can be regulated.
ROLE OF ESTRADIOL IN THE CORTEX
Neuromodulation of synaptic plasticity is thought to be a key
mechanism inﬂuencing information storage (Bavelier et al., 2010).
Recent evidence has demonstrated that estrogens can inﬂuence
behaviors, cellular mechanisms, and signaling pathways within
minutes (Balthazart and Ball, 2006; Srivastava et al., 2008, 2010;
Brinton, 2009). Multiple studies have shown that estrogens inﬂu-
ence hippocampally based behaviors. However, estrogens can also
exert powerful actions on cognitive processes that require infor-
mation processing in the cortex and PFC. For example, studies
in non-human primates have investigated the role of estradiol
in cognitive ability mediated by the PFC (see Bailey et al., 2011
for a recent review). In a delay response task, which is mediated
by the dorsolateral PFC, long-term treatment with estradiol in
hormone depletion, ovariectomized (OVX) aged female rhesus
monkeys, perform signiﬁcantly better than OVX vehicle-treated
animals (Hao et al., 2007; Bailey et al., 2011). Interestingly, younger
OVXmonkeys perform equally well when treated chronically with
either estradiol or vehicle, suggesting an age-dependent effect in
this task (Hao et al., 2007; Bailey et al., 2011).
Multiple studies have also investigated the role of acute estra-
diol treatment in a number of tasks involving cortical processing.
In zebra ﬁnch songbirds, estradiol is rapidly (within minutes)
produced in the cortex in response to social interactions (Remage-
Healey et al., 2008). Furthermore, acute blockade of estradiol
production within the cortex disrupts songbird social interac-
tions (Remage-Healey et al., 2010). Studies using female rats have
shown that OVX impaired the acquisition of the working mem-
ory component of a delay match-to-sample task, as assessed by a
T maze paradigm (Gibbs and Johnson, 2008; Sherwin and Henry,
2008). Interestingly, treatment with 17β-estradiol was sufﬁcient
to prevent the loss of the working memory component in this
task (Gibbs and Johnson, 2008; Sherwin and Henry, 2008). Sim-
ilar results were also observed in a study examining the effect of
OVX on the performance of female rats in a two-way active avoid-
ance paradigm, which is dependent on the frontal cortex as well
as the hippocampus. OXV animals displayed a reduced perfor-
mance compared to control, intact animals, whereas OVX animals
treated with 17β-estradiol performed better than both groups in
the active avoidance task (Singh et al., 1994). In another study
using a win-shift version of the radial arm maze to test spatial
working memory, the local administration of estradiol benzoate
into the frontal cortex of OVX female mice 40min prior to test-
ing signiﬁcantly improved performance compared to OVX mice
(Sinopoli et al., 2006). Acute estradiol treatment has also been
shown to increase aggression (Trainor et al., 2007), which is also
associated with PFC processing.
Several studies have used object recognition, which relies on
both cortical and hippocampal processing (Ennaceur et al., 1997;
Barker and Warburton, 2011), to test the ability of estradiol to
rapidly inﬂuencememory processing. In female OVX rats, admin-
istration of 17α-estradiol or 17β-estradiol, either 30min prior
or 30min post-training, was able to enhance memory recogni-
tion/retention (Luine et al., 2003). Interestingly, this enhancement
was not observed when either estradiol isomer was adminis-
tered 2 h post-training (Luine et al., 2003). Similar results were
also observed with intact female rats; female rats in behavioral
estrus and estrus, when circulating estradiol levels are increased
compared to disestrus, displayed enhanced memory recognition
compared to disestrus female rats (Walf et al., 2006). Moreover,
the same study demonstrated that treatment with propyl pyrazole
triol (PPT) or diarylpropionitrile (DPN), synthetic ERs modula-
tors (SERMs) with higher afﬁnities for ERα or ERβ respectively,
were also able to enhance memory performance in object recogni-
tion when administered 30min post-training (Walf et al., 2006).
In mice, treatment with 17β-estradiol immediately post-training,
injected directly into the dorsal third ventricle or dorsal hippocam-
pus, was sufﬁcient to enhance object recognition in middle-aged
femaleOVXmice (Fan et al., 2010). Importantly, this enhancement
was lost following administration of inhibitors for the kinases
ERK (extracellular signal-regulated kinase) 1/2 and PI3K (phos-
phatidylinositol 3-kinase; Fan et al., 2010). Conversely to data
shown in OVX female rats, another study has shown that PPT,
but not DPN, is able to enhance object recognition in OVX female
mice (Walf et al., 2006; Phan et al., 2011). It is of note that ani-
mals were treated 15min prior to training, and that PPT and DPN
were shown to enhance object recognition in female rats when
administered 30min post-training. Thus it is not clear whether the
differences between these studies are due to the timing of estra-
diol administration. Several studies have also investigated themost
effective dose of estradiol in the enhancement of object recogni-
tion (Luine et al., 2003; Inagaki et al., 2010; Phan et al., 2011). These
studies have demonstrated that there is an inverted U-shaped
dose response curve as opposed to a more traditional S-shaped
dose response curve. In OVX female rats, post-training treatment
with 5μg/kg of 17β-estradiol and 1–2μg/kg of 17α-estradiol,
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but not lower or high concentrations were effective in enhanc-
ing object recognition (Inagaki et al., 2010). In female OVX
mice, pre-training treatment with 50 or 75μg (per 30 g mouse)
PPT was sufﬁcient to enhance object recognition, whereas lower
or higher concentrations were not (Phan et al., 2011). Interest-
ingly an inverse U-shaped dose response curve have also been
reported in estradiol-mediated enhancement of spatial memory
(Gresack and Frick, 2006). This suggests that an inverse U-shaped
pattern of estradiol effects on memory may be applicable to a
number of memory tasks, and not limited to those involving cor-
tical processing. Together, these studies demonstrate that acute
estradiol treatment can rapidly inﬂuence behaviors that require
cortical processing, and more so, that this enhancement occurs
in a time-dependent or time-critical manner, and demonstrate an
inverse U-shaped pattern of responsiveness according to the dose
of estradiol used.
DENDRITIC SPINES, A LINK BETWEEN STRUCTURAL AND
FUNCTIONAL PLASTICITY
Synaptic plasticity is the process by which the strength of com-
munication between neurons is regulated in response to stim-
uli. This process has emerged as the strongest candidate cel-
lular mechanism that underlies information storage and pro-
cessing in the brain, and is thought to be achieved by altering
the strength and number of synaptic connections (Chklovskii
et al., 2004; DeBello, 2008; Holtmaat and Svoboda, 2009). In the
mammalian forebrain, the majority of glutamatergic excitatory
synapses found on pyramidal neurons occur on highly specialized
dendritic profusions called dendritic spines (Figures 1A,B). Den-
dritic spines are highly dynamic structures and undergo many
forms of structural modiﬁcation (Figure 1C). Spine remodel-
ing occurs in concert with changes in post-synaptic function,
driven by the trafﬁcking of synaptic glutamate receptors. Dur-
ing development, dendritic spines are required for the forma-
tion of synapses, and thus formation of neural circuits. In the
mature brain, dendritic spines change shape and number in
response to plasticity or in response to a number of extracel-
lular stimuli (Figure 1D). Regulation of dendritic spine struc-
ture modulates synaptic properties of neurons, and the ability
of synapses to undergo plasticity (Bourne and Harris, 2008). It
is this dynamic remodeling of dendritic spine shape and num-
ber that is thought to be essential for the ability of synapses to
undergo long-lasting functional and structural changes, underly-
ing the rewiring of neuronal circuits (Malenka and Nicoll, 1999;
Luscher et al., 2000; Cline, 2003; Figure 1D) thus contribut-
ing to memory and cognition (Holtmaat and Svoboda, 2009;
Kasai et al., 2010). Indeed, recent in vivo imaging studies have
provided strong evidence that concurrent with the acquisition
of learned behaviors there are coordinated changes in synaptic
structure and protein content, leading to the rewiring of neu-
ronal circuits required for information processing and storage
(Holtmaat and Svoboda, 2009; Yang et al., 2009). More recently,
extrinsic signals such as neuromodulators have been shown to
induce changes in dendritic spine morphology (Jones et al., 2009;
Woolfrey et al., 2009; Bavelier et al., 2010), but how such sig-
nals regulate dendritic spine morphology, synapse function, and
FIGURE 1 | Rewiring of cortical circuitry. (A) Confocal image of a
cortical neuron expressing green ﬂuorescent protein (GFP),
exemplifying cortical neuron morphology of a cortical neuron. The main
dendrite is branched and has dendritic spines along its‘length. The
neuron’s axon is much thinner than the dendrite, and has no spines.
Scale bar, 5μm. (B) High magniﬁcation confocal image of dendritic
spine and dendrite of a cortical neurons. (C) Schematic of dendritic
spine plasticity: spines form and grow, undergo either maintenance or
elimination, or change shape and size. Dendritic spines change
morphology in response to numerous extracellular stimuli.
(D) Schematic of cortical circuitry rewiring. The strengthening or
weakening of existing synaptic connections and the addition or
elimination of synaptic connections induced by physiological stimuli,
allows for the bi-directional rewiring of cortical circuits.
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ultimately modulate the rewiring of neuronal circuits is only now
becoming evident.
FUNCTIONAL CORRELATES OF DENDRITIC SPINE
STRUCTURE
Dendritic spines are found in all shapes and forms. All types of
dendritic spines, large or thin, have the potential to make con-
nections with pre-synaptic partners (Bourne and Harris, 2008).
Larger dendritic spines on average feature larger post-synaptic
densities (PSDs; Bourne and Harris, 2008), persist for longer peri-
ods of time (Trachtenberg et al., 2002; Holtmaat and Svoboda,
2009; Kasai et al., 2010) and are resistant to plasticity-inducing
stimuli. These large, stable spines have thus been labeled “mem-
ory spines” (Kasai et al., 2003). Conversely, smaller spines are
often short-lived but can be readily potentiated to become sta-
ble spines, thus acting as highly dynamic “learning spines” (Kasai
et al., 2003). Therefore, according to thismodel, spinemorphology
modulates synaptic properties and the ability to undergo plasticity
(Segal, 2005; Bourne and Harris, 2008). The shape/size of a den-
dritic spine is also thought to describe the functional properties
of synapses. Larger dendritic spines are also associated with larger
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPAR) content, and have largerAMPA responses,whereas thin-
ner/smaller spines have fewer AMPA receptors and small AMPA
responses (Matsuzaki et al., 2001;Noguchi et al., 2011). Thus larger
spines are more stable and form stronger synapses, while thinner
spines are more dynamic and form weaker synapses. However, it is
of note that this is not always the case; recent studies have demon-
strated that in a few circumstances changes in spine size do not
always correlate with synaptic strength (Segal, 2010). Importantly,
structural morphologies are not static, but are highly dynamic,
and can change shape and number in response to a number of
extracellular stimuli. As extrinsic signals, such as neuromodulator
are now known to be plasticity-inducing stimuli (Srivastava et al.,
2008; Jones et al., 2009;Woolfrey et al., 2009; Bavelier et al., 2010),
a major focus of current cellular and molecular neuroscience is
to uncover the mechanisms underlying the control of dendritic
spine shape, size and number, synapse function, via the trafﬁck-
ing of glutamate receptors, and how these changes integrate to
modulate the rewiring of neuronal circuits.
DENDRITIC SPINES PLAY KEY ROLES IN NORMAL BRAIN
FUNCTION
Neural circuits need to exhibit functional plasticity to encode
information about the environment. A variety of stimuli, both
physiological and pathological, can inﬂuence spine dynam-
ics (Alvarez and Sabatini, 2007; Tau and Peterson, 2010;
Figures 1C,D). Sensory experience, as modeled by mouse whisker
stimulation, resulted in a transient increase in dendritic spine
density in the corresponding primary cortical sensory region
(Wilbrecht et al., 2010).On the other hand, selective sensory depri-
vation elicited through whisker trimming increased the fraction
of transient spines (Trachtenberg et al., 2002). Rearing animals
in enriched environments also results in elevated spine density
in forebrain (Bose et al., 2009). Very recent evidence has shown
rapid spine formation and stabilization in association with motor
learning, followed by homeostatic pruning of synapses in layer V
motor cortex (Yang et al., 2009). Thus structural reorganization of
forebrain spiny synapses appears to be a powerful mechanism for
information storage.
WIRING PLASTICITY IS A MECHANISM FOR THE REWIRING
OF CORTICAL CIRCUITS
Based on evidence from in vivo studies, as well as in vitro and the-
oretical work (Chklovskii et al., 2004; Bourne and Harris, 2008;
Kasai et al., 2010; Segal, 2010), two methods of circuit rewiring
have been proposed. In the ﬁrst instance, changes in the shape
and size of existing synapses, and therefore, the amount of infor-
mation that passes across the synapse, is believed to be a critical
mechanism in underlying information processing and storage in
the cortex. However, in addition to this mechanism, it has been
proposed that information storage can be accomplished through
altering neuronal connectivity, which can be achieved by increas-
ing or decreasing the number of functional synapses between two
cells (Chklovskii et al., 2004; Le Be and Markram, 2006; DeBello,
2008). Together, these two mechanisms have been referred to
as “wiring plasticity,” whereby altering the amount of informa-
tion ﬂow between existing synapses and altering the connectivity
between cells are the underlying mechanisms of neuronal cir-
cuit rewiring, and thus involved in the acquisition of behaviors
(cognitive function; DeBello, 2008; Figure 1D). Indeed, a recent
in vivo imaging study of cortical motor neurons has demonstrated
that there is a concurrent increase in dendritic spine density with
the acquisition of a learned motor behavior (Yang et al., 2009).
Thus the rewiring of cortical neurons appears to be a powerful
mechanism for information storage in the cortex.
DENDRITIC SPINE DYSFUNCTION IN DISEASE
Deﬁcits in cognitive function, notably in working, spatial and ref-
erence memory, as well as social interactions, are core features of a
great number of neurological disorders (DSM-IV, 2000). As den-
dritic spine morphology has been intimately linked to cognitive
function (Ramakers, 2002; Holtmaat and Svoboda, 2009; Kasai
et al., 2010), it is not surprising that multiple neuropathologies are
strongly associated with disruptions of neural circuits (van Spron-
sen and Hoogenraad, 2010; Penzes et al., 2011a). Indeed, numer-
ous neuropathological postmortem studies have strongly linked
abnormal spine morphology with the pathogenesis of a number
of neuropsychiatric disorders and neurodevelopmental disorders
(Fiala et al., 2002; Penzes et al., 2011a); such as mental retardation
(MR; Dierssen and Ramakers, 2006), fragile-X (Irwin et al., 2000),
Down’s syndrome (Takashima et al., 1989), autism spectrum dis-
orders (ASDs; Zoghbi, 2003; Pickett and London, 2005; Hutsler
and Zhang, 2010), schizophrenia (Glantz and Lewis, 2000; Lewis
and Sweet, 2009), depression (Gorman and Docherty, 2010), and
Alzheimer’s disease (DeKosky and Scheff, 1990; Selkoe, 2002). It
is currently posited that dendritic spine dysmorphogenesis can
lead to defective or excessive synapse function and connectivity,
resulting in disruptions in neural circuitry. This topic has recently
been reviewed in depth (Tau and Peterson, 2010; van Spronsen
and Hoogenraad, 2010; Penzes et al., 2011a). Dysregulation of the
complex mechanisms that control dendritic spine structure and
function may contribute to these synaptic irregularities. Under-
standing themechanisms bywhich dendritic spinemorphogenesis
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occurs will therefore, not only expand our knowledge of normal
brain function, but that of abnormal brain function as well.
MOLECULAR CONTROL OF DENDRITIC SPINE MORPHOLOGY
Recently major advances have been made into our understand-
ing of the mechanisms that underlie changes in synapse structure.
The post-synaptic density contains hundreds of distinct proteins,
and the organizational complexity of this structure is becoming
increasingly apparent (Figure 2A). A signiﬁcant challenge is to
identify the proteins that are responsible for determining post-
synaptic ultrastructure. Dendritic spines are actin rich structures
(Figure 1B); actin is the primary cytoskeletal component in spines,
and actinmodulation is essential for changes in spinemorphology
(Frost et al., 2010; Hotulainen and Hoogenraad, 2010). Multiple
signaling pathways are know to converge on the actin cytoskele-
ton, and stimuli that induce ﬁlamentous actin rearrangements are
associated with the formation, elimination, and changes in mor-
phology of dendritic spines (Lise and El-Husseini, 2006; Tada and
Sheng, 2006; Xie et al., 2007, 2008; Penzes et al., 2008; Srivastava
et al., 2008; Jones et al., 2009;Woolfrey et al., 2009; Yoshihara et al.,
2009). One family of proteins that have been shown to have potent
effects on the actin cytoskeleton are the small GTPases.
Small GTPases are G proteins that comprise a superfamily
of more than 100 proteins with diverse cellular functions. As
their name implies, these proteins are of low molecular weight
(20–40 kD) and are related to heterotrimeric G-proteins (e.g., Gs
and Gi). These proteins are highly evolutionarily conserved and
expressed in many tissues including brain (Takai et al., 2001).
There are ﬁve families (Ras, Rho, Rab, Sar1/Arf, and Ran) within
the small GTPase superfamily which are categorized by struc-
ture and function. All small GTPases have a similar structure
which permits binding to GDP and GTP (Takai et al., 2001).
Diversity in small GTPases arises from unique effector-interacting
domains and C-terminal regions which can be modiﬁed by post-
translational modiﬁcation. The ability of Rho- and Ras-family
GTPases to regulate cytoskeleton dynamics and gene transcription
places themas idea candidates to control fundamentally important
neuronal functions.
ESTRADIOL RAPIDLY REMODELS DENDRITIC SPINES OF
CORTICAL NEURONS
As described above, there is ample evidence that estrogens can
rapidly modulate cognitive processes that are mediated by distinct
cortical regions. Previous studies have investigated the effect of
estradiol on dendritic spines of pyramidal neurons in the dorsolat-
eral cortex of young and aged rhesus monkeys (Hao et al., 2007).
Long-term replacement with estradiol in OVX rhesus monkeys
was sufﬁcient to increase spine number compared to vehicle-
treated animals (Hao et al., 2007; Dumitriu et al., 2010). While
these study demonstrates a role of long-term estrogenic treatment
in controlling dendritic spine number, it is not clear what effects
acute estradiol has on synapses. To understand whether estradiol
can acutely modulate dendritic spine morphology of cortical neu-
rons, we investigated the ability of 17 β-estradiol (estradiol), to
alter the shape/size or number of dendritic spines in mature (ado-
lescent) cultured cortical neurons; at this time point, dendritic
spines display a mature morphology, exhibiting a distinct head
FIGURE 2 | Dendritic spines are small protrusions along dendrites that
contain post-synaptic densities. (A) Schematic of a mature dendritic
spine making contact with an axon. Dendritic spines display a typical
morphology of a spine neck and spine head. Cross section of spine reveals
that a number of proteins ranging from neurotransmitter receptors (e.g.,
glutamate receptors) and scaffold proteins (e.g., PSD-95) reside within the
post-synaptic density. Furthermore, actin, signaling proteins and other
signaling proteins (e.g., small GTPases) are also found in dendritic spines,
demonstrating the organizational complexity of dendritic spines. (B) High
magniﬁcation confocal image of a cortical neuron expressing GFP-fused
β-actin. Note the enrichment of β-actin in dendritic spines.
structure, and containing PSD-95 (Xie et al., 2007; Srivastava et al.,
2008, 2010; Jones et al., 2009; Woolfrey et al., 2009; Figures 1B
and 2A).
Treatment with a physiologically relevant concentration of
estradiol (10 nM) resulted in an increase in the number of den-
dritic protrusions 30min following treatment. Interestingly, this
increase in spine number disappeared after 60min, and the num-
ber of dendritic protrusions return to control levels. Time-lapse
imaging further demonstrated that it was the estradiol-induced
dendritic protrusions that were selectively eliminated, indicat-
ing that estradiol’s effects on spines were transient (Figure 3A).
Importantly, these estradiol-induced protrusions were shown to
be functional dendritic spines as they were juxtaposed to pre-
synaptic terminals; non-functional dendritic protrusions, known
as ﬁlopodial protrusions, do not make synaptic contacts. Close
examination of dendritic spine morphology following estradiol
treatment, revealed that estradiol-induced spines had a “thin” like
morphology. This spine morphology is associated with highly
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dynamic synapses that can be either readily potentiated and stabi-
lized, or eliminated (Xie et al., 2005; Penzes et al., 2011b). Owing
to the suggestion that estradiol may act as a neuromodulator, we
speculated that the time that estradiol is present at synapses may
be tightly regulated. Indeed, several enzymes that are involved in
metabolism of estradiol have been detected with the brain (Balt-
hazart and Ball, 2006). Exposure of cortical neurons with estradiol
for 5min to mimic the rapid removal of the neurosteroid from
synapses, elicited the same transient increase in spine density as
the continued presence of estradiol in the experimental medium.
Together, these data suggest that acute estradiol treatment is
able to induce a transient increase in the number of dendritic
spines, without affecting existing dendritic spines (Figure 3A).
These results parallel a recent study of estradiol remodeling of
dendritic spines in CA1 cells of hippocampal slices cultures, which
demonstrated that estradiol induces spine formation without
affecting pre-established networks (Mendez et al., 2010). Inter-
estingly, this rapid and transient effect of estradiol on mature
cortical neurons has also been described in young, developing
cortical neurons. Treatment of young neurons with the same
concentration of estradiol resulted in a rapid, yet transient,
increase in the number of dendritic protrusions, in a similar
time frame (Sanchez et al., 2009). It is also of note that rapid
estradiol-induced spinogenesis in mature cortical neurons were
not dependent on N -methyl-d-aspartic acid receptor (NMDAR)
activity, as estradiol-induced spinogenesis occurred in the pres-
ence or absence of NMDAR blockade (Srivastava et al., 2008).
In hippocampal neurons NMDAR activity is required for rapid
estradiol-induced spinogenesis (Mukai et al., 2007), indicating that
the actions of estradiol in cortical neurons employ distinct mole-
cular mechanism(s) that those initiated in hippocampal neurons
to induce changes in spine morphology.
MOLECULAR MECHANISMS OF ESTRADIOL MODULATION OF
DENDRITIC SPINE STRUCTURE
Dendritic spines are highly specialized signaling compartments
containing numerous signaling proteins, and a major compo-
nent of these structures is the actin cytoskeleton (Figures 2A,B).
Rearrangements of the cytoskeleton, driven by actin polymeriza-
tion and depolymerization, are thought to be a key mechanism
underlying the dynamic regulation of spine structure (Tada and
Sheng, 2006; Yoshihara et al., 2009). Multiple signaling pathways,
particularly those involving Rho- and Ras-family small GTPases,
have been shown to converge on the cytoskeleton to regulate actin
rearrangement, thus underlying the formation, elimination, and
stabilization of dendritic spines (Tada and Sheng, 2006; Penzes
et al., 2008, 2011b; Yoshihara et al., 2009). Estradiol has been
shown to regulate both small GTPase signaling and actin dynamics
FIGURE 3 | Estradiol-induced “two-step wiring plasticity.”
(A) Schematic of estradiol-induced spinogenesis and glutamate receptor
trafﬁcking. Treatment with 17 β-estradiol induces the formation of novel
spines, which form connections with pre-synaptic partners within 30min.
Concurrently GluA1-containing AMPARs are removed from existing spines,
and GluN1-containing NMDARs are trafﬁcking into nascent spines. The effect
is transient, as by 60min, estradiol-induced spines are preferentially
eliminated, GluA1-containing AMPARs and GluN1-containing NMDARs return
to control levels. (B) Schematic representation of Rap/ERK1/2/AF-6 pathway
required for estradiol-induced spinogenesis. Note, both ERK1/2 and AF-6 are
downstream of Rap signaling, but may act in a parallel manner to increase
spine density. (C) Model of Two-StepWiring Plasticity (TSWP). TSWP can be
divided into three distinct phases Phase 1: estradiol increases the number of
connections between cells, synaptic communication is reduced. Phase 2a:
number of connections return to control levels, synaptic communication
returns to normal. OR Phase 2b: synaptic activity-like stimulus leads to
long-lasting (24 h) increase in connectivity and increase synaptic
communication.
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in non-neuronal cells (Sanchez et al., 2010a), but it is not clear if
these pathways are required for the remodeling of dendritic spines
of cortical neurons.
The morphology of estradiol-induced nascent spines provided
us with the ﬁrst insight into the potential underlying molecular
pathways required for the increase in dendritic spine density. Pre-
vious studies have shown that activation of Rap, a member of the
Ras-family of small GTPases, results in the formation of highly
dynamic and “thin” dendritic spines (Xie et al., 2005; Woolfrey
et al., 2009; Penzes et al., 2011b). Following estradiol treatment
activeRap levelswere increased in a time-dependentmannermim-
icking the effect of estradiol on spine density. In situ inhibition
of Rap signaling by overexpression of RapGAP, a protein that
inhibits Rap activity, or of a dominant-negative Rap construct,
blocked estradiol-induced spinogenesis. In contrast, pharmaco-
logical inhibition of the closely related small GTPase Ras did not
block estradiol-induced nascent spines. When the activity of Rac,
a Rho-family small GTPase, was examined, a modest decrease in
Rac levels after 60min of estradiol treatment was observed. It is
possible that this small inhibition in Rac activity is sufﬁcient to
drive estradiol-induced spine numbers back to a level similar to
control, as previous studies have shown that inhibition of Rac
reduces spine numbers (Tashiro and Yuste, 2004).
Further investigation of the downstream targets of Rap signal-
ing revealed that the MAP kinases, ERK1/2 (extracellular signal-
regulated kinase) was required for estradiol-induced spinogenesis.
Importantly, ERK1/2 activation has been shown to be required
for the remodeling of dendritic spines, acquisition of learning
and memory, and is a common downstream target of estra-
diol in a number of cell types (Thomas and Huganir, 2004; Raz
et al., 2008). The protein AF-6 (also known as afadin), which is a
PDZ domain-containing and F-actin-binding protein, previously
shown to be regulated by Rap and is required for Rap-dependent
spine plasticity (Xie et al., 2005), was clustered to synapses in
response to estradiol treatment, paralleling estradiol’s effects on
spine density. Furthermore, estradiol-dependent spine formation
was prevented by the expression of a mutant AF-6 with an inactive
PDZ domain. Taken together, these data suggested that estra-
diol signaling via a Rap/ERK/AF-6-dependent pathway is required
for increased dendritic spine number in mature cortical neurons
(Figure 3B).
In young, developing cortical neurons, estradiol-mediated
increases in dendritic protrusions required the activation of a
c-SRC/Rac1/Cdk5/WAVE1/Arp2/3 pathway, in parallel with acti-
vation of a RhoA/ROCK-2/moesin cascade (Sanchez et al., 2009).
Elucidation of these pathways directly link estradiol signaling with
the rearrangement of the actin cytoskeleton via WAVE1/Arp2/3
and moesin. It is of note that these pathways are different from
those activated in mature cortical neurons by estradiol. One
potential explanation of this difference could be attributed to
the differential expressing of signaling proteins and thus the
coupling of estradiol to different intracellular pathways depen-
dent on the developmental time point. Upstream regulators of
small GTPase pathways have been shown to be developmentally
regulated (Penzes et al., 2008), and the local environment of
signaling pathways that link ERs with such small GTPase path-
ways may also be developmentally regulated. Put together, it is
possible that during a young developmental time point, parallel
activation of a c-SRC/Rac1/Cdk5/WAVE1/Arp2/3 pathway and
a RhoA/ROCK-2/moesin cascade is required for the formation
of potential synaptic connections, whereas mature cortical neu-
rons, with pre-existing synaptic connections, require an inter-
play between a Rap/ERK1/2/AF-6 and Rac-dependent pathways
in order to induce a transient increase in synaptic connectivity.
Interestingly, a recent study of rapid estradiol actions in CA1
hippocampal cells demonstrated that estradiol increased the poly-
merization of actin in a RhoA/ROCK/coﬁlin-dependent pathway
(Kramar et al., 2009). Moreover, estradiol has been shown to reg-
ulate the expression and activity of LIM kinase (LIMK) in CA1
neurons (Yildirim et al., 2008; Yuen et al., 2011). As activation
(phosphorylation) of LIMK can control the polymerization of
actin through the actin binding protein, coﬁlin, estradiol regula-
tionof LIMKcouldprovide anothermechanismbywhich estradiol
can control actin dynamics in pyramidal neurons. The dispari-
ties in the elucidated mechanisms required for estradiol-mediated
spinogenesis in cortical neurons and hippocampal could be due to
several reasons. It is possible that differences in the cell prepara-
tions (i.e., ex vivo versus in vitro) or age of neurons underlie these
differences. However, it is more likely that these differences arise
due to cell type speciﬁcity, thus suggesting that neurons from sepa-
rate regions of the brain employ distinct molecular mechanism to
transduce rapid estrogenic signaling into morphological changes.
Ultimately, these discrete mechanisms may be important for how
estradiol modulates neuronal circuitry in each area.
THE ROLE OF ERβ IN SPINE FORMATION IN CORTICAL
NEURONS
Investigations into the expression proﬁle of ERs have indicated
that ERβ is highly expressed in the mammalian cortex, but less so
in the hippocampus; the expression proﬁle of ERα is thought to
be higher in the hippocampus compared to the cortex (Kritzer,
2002). Previous studies investigating which ER is required for
rapidly induced morphological changes in hippocampal neurons
have suggested that ERα but not ERβ is required for rapid increases
in dendritic spine density (Mukai et al., 2007). However, owing to
the increased expression of ERβ compared to ERα in cortical neu-
rons, we hypothesized that activation of ERβ may be sufﬁcient to
induced rapid morphological changes in mature cultured corti-
cal neurons. Treatment of cortical neurons with WAY-200070, an
ERβ-speciﬁc agonist (Liu et al., 2008), resulted in a rapid (within
30min) increase in dendritic spine density (Srivastava et al., 2010).
The majority of these spines were positive for overlap with the
pre-synaptic marker bassoon, suggesting that ERβ-induced spines
were making connections with pre-synaptic termini (Srivastava
et al., 2010). Moreover, these spines also contained the post-
synaptic protein, PSD-95, further indicating that ERβ-induced
spines were forming functional connections. Interestingly, there
was no increase in the overall expression of PSD-95 following acute
treatment with WAY-200070. Rather, a redistribution of PSD-95
was observed following treatment with WAY-200070; a concur-
rent increase in membrane PSD-95 was seen with a reduction in
cytosolic PSD-95, suggesting that the recruitment of PSD-95 from
cytosolic clusters within the dendritic shaft to dendritic spines
resulted in the enrichment of ERβ-induced nascent spines with
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PSD-95 (Srivastava et al., 2010). Examination of the signaling
pathways activated following ERβ stimulation revealed an increase
in the phosphorylation (activation) of PAK and ERK1/2, provid-
ing a potential signaling cascade linking ERβ with cytoskeleton
rearrangements underlying changes in dendritic spine density.
Together these data suggest that activation of ERβ in cortical neu-
rons is capable of increasing functional dendritic spine numbers,
via a PAK/ERK1/2 pathway, in a rapid time frame.
ESTRADIOL RAPIDLY MODULATES GLUTAMATE RECEPTOR
TRAFFICKING
A widely accepted view is that the rapid trafﬁcking of the glu-
tamate receptors N -methyl-d-aspartic acid (NMDARs) and α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors
(AMPARs) is a key mechanism in controlling synaptic commu-
nication. Multiple studies have indicated that structural and func-
tional changes in synapses often go hand in hand (Matsuzaki et al.,
2001). However, this is not always the case (Segal, 2010). Recent
studies have demonstrated that synapses can contain NMDARs,
but lack AMPARs. These synapses, termed “silent synapses” are
thought to be rapidly potentiated during plasticity, and are amajor
mechanism for the remodeling of neuronal circuits (Ashby and
Isaac, 2011). Estradiol has been shown to increase the responses
to long-term potentiation (LTP) and long-term depression (LTD)
at hippocampal synapses (Mukai et al., 2007; Woolley, 2007; Kra-
mar et al., 2009). But whether estradiol regulates the trafﬁcking of
NMDARs or AMPARs in cortical neurons is not clear.
To examine whether acute estradiol treatment affected glu-
tamate receptor trafﬁcking, we investigated with localization of
NMDAR and AMPARs subunits following treatment with estra-
diol. Acute treatment with estradiol in cortical neurons induced
the removal of the GluA1-containing AMPARs from synapses
at 30min, while inducing insertion of the GluN1-containing
NMDARs. Remarkably, by 60min of treatment,GluA1 andGluN1
content had returned to control levels. Time-lapse imaging of
GFP-tagged GluA1 demonstrated that GluA1 was being internal-
ized frompre-exiting dendritic spines, and returning into the same
spine,without entering nascent spines (Figure 3A). To understand
the functional outcome of this trafﬁcking we measured AMPAR-
mediated miniature excitatory post-synaptic currents (mEPSCs).
Consistent with GluA1 trafﬁcking, electrophysiological analysis
demonstrated that estradiol-induced a transient reduction in
AMPAR-mediated mEPSC frequency, but not amplitude, indicat-
ing a change in the number of active synapses (Srivastava et al.,
2008). Together, these data indicated that estradiol may tran-
siently increase in the number of synapses containing NMDARs
but lacking AMPARS and thus the number of silent synapses
(Figure 3A).
Previous studies have shown that activationof the smallGTPase
Rap can lead to the internalization of AMPARs (Xie et al., 2005;
Woolfrey et al., 2009). As estradiol treatment results in the activa-
tion of Rap, it is likely that a Rap-dependent mechanism underlies
the rapid internalization of GluA1 in cortical neurons. Interest-
ingly estradiol treatment of hippocampal neurons resulted in
the rapid increase in levels of membrane GluA1, via a MAP
kinase/calpain pathway (Zadran et al., 2009). It is likely that the
differences seen in GluA1 trafﬁcking in hippocampal and cortical
neurons is due to the different signaling mechanisms activated by
estradiol in these different cell types.
ESTRADIOL-INDUCED “TWO-STEP WIRING PLASTICITY”
The ability of estradiol to rapidly induce spine formation, and
silence a subset of synapses, led us to question: what is the phys-
iological role of such a transient increase in silent synaptic con-
nections; what relevance it has for the rewiring of cortical circuits;
how do these effects relate to estradiol’s ability to rapidlymodulate
information encoding?
In vivo imaging studies have very elegantly demonstrated that
cortical circuits are remodeled in a physiologically relevant man-
ner; however, the underlying molecular and cellular mechanisms
are still somewhat of a mystery. Theoretical studies have posited
that there is sufﬁcient overlapbetweendendrites and axons (poten-
tial synapses) to allow additional synapses to occur (Chklovskii
et al., 2004). In vivo work has also shown that neurons can spon-
taneously make transient synapses. These nascent connections are
thought to “sample” pre-synaptic contacts, but are not considered
to be functional. These novel connections are not permanent and
retract unless a subsequent Hebbian-like, or activity-dependent
stimulus, is provided which stabilizes or “holds” the nascent con-
nections (Holtmaat et al., 2005). Furthermore, this activity-like
stimulus is also thought to potentiate these connections, making
them functional (Chklovskii et al., 2004; Holtmaat et al., 2005).
Therefore, it has been posited that information can be stored
through a “sample and hold” or “Two-Step” model (Holtmaat
et al., 2005). Under this theoretical framework, novel dendritic
spines “sample” pre-synaptic contacts, but will retract without
subsequent Hebbian-like mechanisms that reinforce or “hold”
nascent connections. Thus, this model represents a mechanism
that features enormous capacity for cortical information stor-
age (Chklovskii et al., 2004; Le Be and Markram, 2006). Such
alterations in synapse number may result in both increased and
stronger connectivity between neurons, and thus constitutes a
novel form of “wiring plasticity” (Chklovskii et al., 2004;Holtmaat
et al., 2005; Le Be and Markram, 2006; DeBello, 2008; Holtmaat
and Svoboda, 2009; Figure 1D). Although this phenomenon has
been observed in vivo (Holtmaat et al., 2005; Le Be and Markram,
2006), the physiological signals and molecular mechanisms that
govern this form of plasticity are not known.
Based on these observations, we hypothesized that estradiol’s
ability to transiently induce nascent silent synaptic connections
may serve to “prime” neurons to respond to activity-dependent
stimuli with greater efﬁcacy thus participating in “Two-Step”
model of wiring plasticity. Estradiol-induced thin spines would
sample the pre-synaptic environment forming nascent synapses
that contain NMDARs but lacked AMPARs. If a second stimu-
lus is not applied, these novel connections retract, allowing the
cell to return to its “resting state” (Figure 3A). However, if a sec-
ond, activity-dependent stimulus is applied, these newly formed
synapses may become stabilized and potentiated, leading to an
increase in connectivity between cortical neurons.
Co-treatment of estradiol followed by an activity-dependent
stimulus, achieved by activation of NMDARs by a chemical LTP
paradigm (Xie et al., 2007; Srivastava et al., 2008), resulted in a
stabilization of estradiol-induced spines lasting up to an hour.
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Moreover, this maintained increased spine density persisted for
up to 24 h. Importantly, these spines overlapped with the pre-
synaptic maker bassoon, demonstrating that the combined treat-
ment of estradiol and an activity-dependent stimulus had induced
a long-term increase in connectivity in neurons. Furthermore,
investigations of the effect of these two treatments on synapse
function revealed that there was an increase in the surface expres-
sion of GluA1 at synapses which was paralleled by an increase in
AMPAR-mediated transmission (Figure 3C). Consistent with this
ﬁnding,AMPAR-mediatedmEPSCswere also increased compared
to control levels, suggestive of an overall increase in synaptic trans-
mission. Previous reports have demonstrated that CaMKII activity
is required for NMDAR-dependent changes in spine morphol-
ogy and GluA1 insertion into synapses (Xie et al., 2007). Indeed,
we found that the combined treatment of estradiol and activity-
dependent stimuli resulted in an increase in active levels of CaMKII
(Srivastava et al., 2008), suggesting that this kinase plays a role in
mediating the increase in connectivity and transmission by these
two extracellular signals. In summary, these data demonstrate
that the combined treatment of estradiol and activity-dependent
stimulus was able to both induce a long-lasting increase in synap-
tic connectivity and enhance synaptic communication between
neurons (Figure 3C).
ESTRADIOL AND DISEASE
Multiple studies from basic science have demonstrated neuropro-
tective effects by estradiol. Coupled with evidence that estradiol
can induce synaptic enhancements and inﬂuence cognition in a
range of animal models, the use of estradiol as a treatment in a
number of disorders has been investigated.Moreover, estradiol has
been implicated in the onset, clinical course, and symptomatology
of a number of psychiatric andneurodegenerative disorders.While
a number of clinical studies have indicated a beneﬁcial role of
estradiol in a number of disorders (Cyr et al., 2000; Kulkarni et al.,
2008; Hughes et al., 2009; Kulkarni, 2009; Sanchez et al., 2010b),
studies by the Women’s Health Initiative (WHI) and ancillary
studies by WHI Memory Study (WHIMS) have reported conﬂict-
ing results (Rossouw et al., 2002; Espeland et al., 2004; Shumaker
et al., 2004). In these studies, a hormone treatment of conjugated
equine estradiol and medroxyprogesterone were administered to
women of 65 years of age or old. These randomized control tri-
als did not ﬁnd any effect in protection against cognitive decline.
Conversely, they suggested a potential increase in cognitive decline
and increased risk for a number of risk factors for cardiovascular
problems, stroke, and cancer (Rossouw et al., 2002; Espeland et al.,
2004; Shumaker et al., 2004). While there is controversy regarding
the results of these ﬁndings (Craig et al., 2005), it is clear that cau-
tion must be taken when examining the potential beneﬁcial effects
of estradiol in a number of disorders. Moreover, it may also be
suggested that the use of alternative approaches to mimic estra-
diol’s positive effects, by modulating speciﬁc ERs (Hughes et al.,
2009) and/or regulating estradiol intracellular molecular targets,
may offer an avenue of treatment that may allow for the beneﬁcial
effects of estradiol without the harmful side effects. Here we will
highlight some of the evidence and potential molecular basis for
estradiol’s role in a number of neurodegenerative and psychiatric
disorders.
ESTRADIOL AND SCHIZOPHRENIA
Schizophrenia is a devastating disorder that affects 0.5–1% of
the population. Deﬁcits in cognitive function, notably in work-
ing memory, are a core feature of this disorder, and dendritic
spinemorphology has been intimately linked to cognitive function
(Lewis and Sweet, 2009). While current anti-psychotic treatments
have had some success in the management of the positive symp-
toms of schizophrenia, cognitive functional deﬁcits have been
more difﬁcult to treat (Lewis and Sweet, 2009). Numerous clini-
cal, epidemiological, and postmortem studies have strongly linked
abnormal spine morphology, and disruptions in endocrine sig-
naling with the pathogenesis of schizophrenia (Hill et al., 2006;
Lewis and Sweet, 2009).Multiple studies have suggested that estra-
diol may have neuroprotective properties against this disorder,
and several clinical trials have found that estradiol, in conjunc-
tion with ongoing treatments with anti-psychotics, has partial
success at ameliorating schizophrenic symptoms in females (Men-
drek, 2007; Mortimer, 2007; Kulkarni et al., 2008). Interestingly,
a recent clinical trial has also demonstrated a positive role for
estradiol, administered in addition to anti-psychotics, in the treat-
ment of schizophrenic symptoms in males, leading to the authors
proposing that estradiol may be an effective treatment in males
as well (Kulkarni et al., 2011). However, it is important to note
that these trials were short-term, lasting up to 28 days. As such,
the potential beneﬁts of long-term effects of adjunct treatment
of estradiol with ongoing anti-psychotic drugs have yet to be
investigated. The etiology of schizophrenia appears to involve a
number of genetic and environmental components, resulting in
a pathogenic mechanism leading to molecular and cellular dis-
turbances and altered brain function. While clinical studies have
reported that estradiol can ameliorate schizophrenic symptoms,
the mechanisms underlying the beneﬁcial effects of estradiol are
not well understood. Recent studies have shown sequence varia-
tion and lowermRNA of wild type ERα associated in patients with
schizophrenia suggesting that deﬁcient signaling via this receptor
may contribute to the symptomatology of schizophrenia (Perlman
et al., 2005; Weickert et al., 2008). This in turn may affect the abil-
ity of estradiol to regulate dendritic spine density in subjects with
either reduced or variant forms of ERα. Recent studies have also
shown that ERα can interact with ErbB4 in a neuronally derived
cell line (Wong and Weickert, 2009), and furthermore, estradiol
treatment has been shown to regulate ErbB4 expression (Ma et al.,
1999). Importantly, genome-wide association studies have identi-
ﬁed neuregulin-ErbB4 signaling as a major susceptibility pathway
in schizophrenic patients (Jaaro-Peled et al., 2009). Furthermore,
as neuregulin-ErbB4 signaling has been shown to indirectly regu-
late spine density (Li et al., 2007), estradiol-dependent regulation
of ErbB4 expression may offer an indirect pathway in the regu-
lation of dendritic spines in subjects with schizophrenia. Taken
together, these preclinical and clinical studies suggest that target-
ing estrogenic signaling may be a viable option for the treatment
of schizophrenia in male and female patients.
ESTRADIOL AND DEPRESSION
Major depression is a disease that is strongly associated with sex
differences in the predominance of this disease being higher in
females and the onset of this disease also being younger in female
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subjects compared to males. This has lead to the suggestion that
estradiol signaling may be involved in this disease (Weissman
et al., 1993; Hughes et al., 2009). Multiple lines of evidence have
been provided suggesting that a loss of synaptic connections in
subjects suffering from major depression contributes to the etiol-
ogy of this disorder (Nestler et al., 2002; Gorman and Docherty,
2010; Soetanto et al., 2010). As with most psychiatric disorders,
the underlying pathogenesis of this complex disease involves an
integration of multiple factors ranging from environment to mol-
ecular and genetic components. Clinical studies have suggested
that estradiol or hormone replacement in combination with anti-
depressants may be beneﬁcial in some case (de novaes Soares
et al., 2001; Morgan et al., 2005; Rasgon et al., 2007; Zanardi et al.,
2007). However, these ﬁndings are inconsistent and more anecdo-
tal observations. Preclinical studies of animal studies of depression
have also shown an anti-depressive effect of estradiol. In a learned
helplessness model of depression in rats, estradiol treatment was
able to improve escape performance and rescue stress-induced
loss of dendritic spines of CA1 neurons in OVX females (Hajszan
et al., 2010). In aged intact femalemice, administration of estradiol
1 h prior to testing demonstrated anti-anxiety and anti-depressive
effects in a number of anxiety-like and depressive-like behav-
iors (Walf and Frye, 2010), suggesting that estradiol via a rapid
mechanism may have anti-depressive effects. In addition, investi-
gations in ER knockout mice have shown that loss of ERβ results
in an increase in depressive and anxious behaviors (Kre¸z˙el et al.,
2001; Rocha et al., 2005). Moreover, treatments with estradiol, or
ERβ agonists speciﬁcally, were enough to reduce these abnormal
behaviors (Hughes et al., 2008; Walf et al., 2008). However, the
mechanisms that underlie estradiol’s potential beneﬁcial effects in
depression are not clear. Several studies have shown that mRNA
levels of ERα are reduced in subjects with major depression (Perl-
man et al., 2004, 2005) and that SNPs of the ER alpha gene are
associated with patients with major depression (Mill et al., 2008).
The reduction in ERα expression may offer a mechanism that is
disrupted in major depression leading to a reduction in dendritic
spine number. Interestingly, reduced levels of brain-derived neu-
rotrophic factor (BDNF) have also been associated with major
depression (Shalev et al., 2009; Gorman and Docherty, 2010).
Estradiol has been shown to increase the production of BDNF
(Scharfman and MacLusky, 2006), and a functional interaction
between the TrkB receptor and ERα has also been demonstrated
(Wong et al., 2011). This ﬁnding, in combination with evidence
thatBDNFcan regulate dendritic spinemorphology (Verpelli et al.,
2010), suggests that an integration of these two signaling path-
ways may contribute to the beneﬁcial role of estradiol in major
depression.
ESTRADIOL AND ALZHEIMER’S DISEASE
Alzheimer’s disease is the most common form of dementia.
Although amyloid plaques, neuroﬁbrillary tangles and cell death
are deﬁning characteristics of Alzheimer’s disease, ﬁnding from
neuropathological studies have consistently reported prominent
synapse loss (DeKosky and Scheff, 1990; Selkoe, 2002). Familial
Alzheimer’s disease has been associated with mutations in APP,
PSEN1, and PSEN2, genes essential for the production of beta
amyloid (Aβ). Mutations in these genes result in an increase in
Aβ production, and several cellular studies have provided com-
pelling evidence that soluble Aβ oligomers reduce spine density
(Selkoe, 2008). On the other hand, the emergence of Alzheimer’s
disease after age 65, referred to as late-onset Alzheimer’s disease
(LOAD)accounts for the vastmajority ofAlzheimer’s disease cases.
Although numerous genes have been proposed as LOAD risk fac-
tors, the gene encoding apolipoprotein E (APOE) is considered
to be the most important risk factor for LOAD (Sleegers et al.,
2010). The evidence of the involvement of estrogens inAlzheimer’s
disease comes from epidemiological studies demonstrating that
the risk for females developing Alzheimer’s disease signiﬁcantly
increases following menopause (Henderson, 2009). Furthermore,
studies have also detected lower levels of estradiol and reduced aro-
matase expression within the brains of females with Alzheimer’s
disease (Yue et al., 2005). In addition, genetic studies have also
shown an association between variants of the gene CYP19a (aro-
matase; Iivonen et al., 2004), altered levels of ERα mRNA and
protein (Ishunina and Swaab, 2008), and variants in the ERβ gene
(Pirskanen et al., 2005) with risk for Alzheimer’s disease. Sev-
eral clinical studies have suggested a beneﬁcial role of estradiol
plus progestin in the treatment of Alzheimer’s disease (Resnick
et al., 2006); however, this beneﬁcial role has also been challenged
(Rossouw et al., 2002; Rapp et al., 2003; Espeland et al., 2004;
Shumaker et al., 2004). Preclinical studies have also supported a
role of estradiol in a neuroprotective role. Disruption of estradiol
signaling in mouse models of Alzheimer’s disease resulted in an
accumulation of Aβ (Carroll et al., 2007), whereas replacement
of estradiol following ovariectomy, reduced the accumulation of
Aβ, and improved cognitive performance (Carroll and Pike, 2008).
Other studies have also shown that estradiol treatment can regulate
APOE expression. Activation of ERα up-regulates APOE expres-
sion, whereas ERβ decreases APOE expression (Wang et al., 2006).
Importantly,mice expressingAPOE ε4 (theAPOE allele associated
with the greatest risk of developingAlzheimer’s disease), displayed
reduced dendritic spine number compared with wild type mice
(Dumanis et al., 2009). Conversely, expression of APOE ε2 in a
mouse model of Alzheimer’s disease was reported to restore spine
density to control levels (Lanz et al., 2003). Collectively, these stud-
ies suggest that estradiol may have a beneﬁcial role in Alzheimer’s
disease, and that these effects may be due to its ability to modulate
dendritic spinedensity, either directly via activationof speciﬁcERs,
or in directly, by reducing levels of Aβ, or regulating the expression
levels of speciﬁcAPOE alleles. As described above, studies from the
WHI and WHIMS have failed to support a positive role of estra-
diol in cognitive decline, and in contrast reported increased risk
of cognitive decline and dementia. However, it has also been sug-
gested that there is a critical period, or “window of opportunity,”
in which estradiol can be effective in protecting again cognitive
decline (Gibbs,2000). Indeed evidence frombothbasic and clinical
studies are beginning to support such a critical period hypothesis
(Rocca et al., 2011). Furthermore, a recent study has suggested that
sustaining a sufﬁcient level of ERα expression is required for the
critical period, thus offering an insight into the potential mecha-
nisms underlying this window of opportunity (Zhang et al., 2011).
Whether this reduction in ERα levels is a critical mechanism in the
pathophysiology of Alzheimer’s disease, or whether this pertains
solely to this hypothesis is also unclear at this point.
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POTENTIAL CELLULAR MECHANISMS UNDERLYING BENEFICIAL ROLES
OF ESTRADIOL IN DISEASE
The pleiotropic effects of estrogens in the CNS demonstrate that
there are potentially multiple different mechanisms by which it’s
beneﬁcial andneuroprotective effectsmay be exerted. Studies from
primary neuronal cultures have revealed that estradiol is neu-
roprotective in response to glutamate toxicity. Moreover, both
ERα and ERβ have been implicated in this role. Neuronal via-
bility has been shown to be increased following acute treatment
with estradiol, and is dependent on a SRC/ERK/CREB/BCL-2
pathway (Singer et al., 1999; Wu et al., 2005). In addition, the
coupling of ERα to Gβ/γ G protein subunits has been shown to be
required for hippocampal cell survival following NMDA-induced
excitotoxicity (Dominguez et al., 2009). However, in addition to
these mechanisms of neuroprotection, the potential beneﬁcial
role of estradiol in neurodegenerative and psychiatric disorders
may also be mediated by estradiol’s effects on neuronal circuitry.
As described above, several of these disorders display aberrant
dendritic spine morphology, and thus being able to modulate
these synaptic structures may offer a potential therapeutic avenue.
Speciﬁcally, as our data suggest that estradiol is able to“prime”cor-
tical neurons to respond to subsequent activity-dependent stimuli,
it is interesting to speculate that such a two-step form of plasticity
would allowneurons tomakenovel connections that have been lost
due to a pathogenic insult. In agreement with this hypothesis, it is
interesting to consider that the anti-depressive effect of estradiol
in a learned helplessness model of depression is coupled with an
increase in spinogenesis inCA1neurons (Hajszan et al., 2010). Fur-
thermore, activation of ERβ has anti-depressive-like effects (Walf
et al., 2008), and activation of ERβ can increase spine density
in cortical neurons (Srivastava et al., 2010). Moreover, a recent
study has demonstrated that rapid estradiol signaling, acting via
a mechanism almost identical to “two-step wiring plasticity,” has
shown that estradiol treatment is sufﬁcient to ameliorate spine loss
induced by soluble Aβ (Logan et al., 2011). Despite the potential
beneﬁcial effects of estradiol in neurodegenerative and psychiatric
disorders, it is important to take into account the potential harmful
side effects. As such, a greater understanding of the molecular and
cellular mechanisms underlying both estradiol’s effects on neuro-
protection and on neuronal circuitry will hopefully identify new
targets in the development of certain CNS disorders.
CONCLUSION AND FUTURE DIRECTIONS
Our cellular and molecular studies into rapid action of estra-
diol on cortical neurons have led us to propose the following
model: estradiol can rapidly “prime”neurons to respond to subse-
quent synaptic activity-like stimuliwith greater efﬁcacy (Srivastava
et al., 2008). This is achieved by estradiol modulation of spine
structure and functional in neural circuits. To understand the
complex mechanisms underlying this form of wiring plasticity
termed “Two-Step Wiring Plasticity,” we have divided it into three
conceptual phases (see Figure 3C):
Phase 1: Estradiol transiently increases the number of
dendritic spines, and generates silent synapses by removing
GluA1-containing AMPARs from existing and inserting GluN1-
containing NMDARs into nascent synapses. Increased connec-
tivity and generation of silent synapses places the neurons in a
“primed”state, ready to respond to subsequent stimuli with greater
efﬁcacy.
Phase 2a: Without a second stimulus, estradiol-induced
novel spines are preferentially eliminated, and GluA1-containing
AMPARs and GluN1-containing NMDARs return to pre-existing
spines. This mechanism allows the cell to return a “resting state.”
Phase 2b:Addition of a subsequent activity-dependent stimulus
leads to persistence of estradiol-induced spines and the trafﬁck-
ing of GluA1-containing AMPARs into both pre-existing and
novel spines. This results in long-term (24 h) increased synaptic
connectivity and transmission.
Elucidation of the molecular pathways activated following
acute estradiol treatment may offer an insight into the critical
signals required for this form of wiring plasticity to occur. Acti-
vation of a Rap/AF-6/ERK1/2 pathway is critical for the estradiol-
mediated increase in spine density seen in phase 1 (Figure 3B).
During phase 2a, it is possible that a decrease in Rac activitymay be
required to induce the retraction of estradiol-induced spines. Con-
versely, during phase 2b activation of Rac via anNMDAR/CaMKII
pathway as previously shown (Xie et al., 2007) is required for
the stabilization of nascent spines and the potentiation of silent
synapses (Figure 3C). Together this model of two-step wiring
plasticity demonstrates how estradiol may act to prepare a cell to
respond to activity-dependent stimuli with greater efﬁcacy, result-
ing in an increase in connectivity and communication between
neurons, leading to a rewiring of cortical circuits. This in turn
may contribute to the mechanism(s) by which estradiol inﬂuences
cognitive function.
It is of note that these studies were performed using an in vitro
system, which may also be the basis for the differences seen in
estradiol’s actions in different brain areas. In the future it will
be important to conﬁrm the effects of two-step wiring plastic-
ity within more intact systems, and eventually in vivo. However,
the use of an in vitro system, such as cultured neurons offers an
excellent platform for dissecting the potential molecular mech-
anisms underlying this form of plasticity. Based on our current
data, it is appealing to speculate that the “priming” of dendritic
spines in cortical neurons may serve to augment the acquisition
or consolidation of certain behaviors. The evidence that acute
estradiol administration in a time-speciﬁc manner pre- or post-
training, is required for the enhancement of object recognition,
may point to a role for this plasticity in the acquisition of learned
behaviors. However, the relationship between estradiol-induced
two-step wiring plasticity and the acquisition, consolidation, or
retrieval of memory needs to be investigated.
Aberrant dendritic spine morphology and number in disease
have implications for both synapse function and circuit-level con-
nectivity. Although the deﬁcits in dendritic spines may be the
original insults contributing to the pathophysiology of a disease,
it is possible that alterations in dendritic spine morphology or
number may be a secondary effect or compensatory effect. Nev-
ertheless, dendritic spines may serve as a common substrate in a
number of psychiatric, neurodevelopmental, and neurodegener-
ative disorders, particularly those involving cognitive deﬁcits. As
modiﬁcations in spine morphology and number are associated
with cognitive function, understanding how extracellular signals
impact spinemorphology,andmoreover theunderlyingmolecular
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mechanisms that are essential for the development of more effec-
tive and speciﬁc therapies for these disorders. The evidence that
estradiol is able to inﬂuence a range of cognitive behaviors, cou-
pled with the ability of this neurosteroid to exert a powerful effect
on dendritic spine morphology and number, identiﬁes estradiol
as a good candidate as a therapeutic target.
The evidence provided by clinical and preclinical studies sug-
gest that estradiol-based therapies are a potential therapeutic
avenue for the treatment of certain complex disorders. How-
ever, as with most estradiol-based treatments, it is important to
remember that the use of estradiol as a long-term treatment is
associated with an increase in risk for the emergence of cardiovas-
cular problems, estradiol-sensitive cancers, and stroke. Because
of the potential detrimental effects of long-term estradiol treat-
ment, the importance of understanding themolecularmechanism
underlying estradiol’s effects on dendritic spines, cognition, and
their potential relevance for both normal and abnormal cognitive
function is necessary. Many of the proteins that are involved in
pathways that regulate dendritic spine morphology are enzymes
that could be targeted with “designer” small molecules and drugs
that target trophic and morphogenic signaling pathways, lead-
ing to alterations in neuronal connectivity, inducing fewer side
effects.
Moreover, as the complexity of estradiol signaling within the
brain is now readily evident, with both rapid and long-term
actions of the steroid, it is critical to understand how both
modes of actions of this steroid integrate to inﬂuence synapse
structure and function, leading to its inﬂuences on cognitive
function. Furthermore, the discrete production of estradiol via
the enzyme aromatase offers an alternative to directly target-
ing estradiol-dependent signaling pathways or ERs. By targeting
the speciﬁc activity of brain-aromatase to regulate brain estra-
diol levels, it may be possible to produce the beneﬁcial effects
of estradiol within the brain, without the adverse side effects
in other tissues. Finally, owing to the multiple lines of evidence
that estradiol cannot only affect the onset, but the progression
and the symptomatology of several diseases, new therapies based
on estrogenic signaling could be used to delay the onset, slow
the progression of disease in an early stage, or mitigate symp-
toms, or even promote functional recovery after a disease is fully
manifested.
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